greeksoup/ stock research

Metlife (MET) FY2020 results: revenue $67.8 billion, down 2.6% on the year

Metlife Inc. (MET) reported revenue of $67.8 billion for fiscal 2020, the year ended 31 December 2020, down 2.6% on the year before. Net income was $5.4 billion, down 8.3%, and diluted earnings per share $5.68. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2021.

Revenue
$67.8 billion
-2.6% on the year
FY2013FY2020
Operating margin
10.2%
9.8% a year earlier
FY2013FY2020
Net income
$5.4 billion
-8.3% on the year
FY2013FY2020
Diluted EPS
$5.68
-6.3% on the year
FY2013FY2020

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2020FY2019FY2018On the yearLast 8 years
Revenue67,84269,62067,941-2.6%
Operating income6,9276,7956,307+1.9%
Operating margin10.2%9.8%9.3%
Interest expense632656827-3.7%
Pre-tax income6,9276,7956,307+1.9%
Income tax1,5098861,179+70.3%
Effective tax rate21.8%13.0%18.7%
Net income5,4075,8995,123-8.3%
Net margin8.0%8.5%7.5%
Diluted EPS$5.68$6.06$4.91-6.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2020FY2019FY2018On the yearLast 8 years
Operating cash flow11,63913,78611,738-15.6%
Cash from investing-18,569-17,586-5,634
Cash from financing10,7294,568-2,801+134.9%
Depreciation and amortisation235249238-5.6%
Share-based compensation12715086.0-15.3%
Buybacks1,1512,2853,992-49.6%
Dividends paid1,6571,6431,678+0.9%
Dividend per share$1.82$1.74$1.66+4.6%
Diluted shares, weighted913m944m1,014m-3.3%
Shares outstanding at period end893m915m959m-2.5%

Balance sheet

$ millionFY2020FY2019FY2018On the yearLast 8 years
Shareholders' equity74,55866,14452,741+12.7%
Non-controlling interest259238217+8.8%
Short-term borrowings393235268+67.2%
Debt14,60313,46612,829+8.4%
Other liabilities705,333660,380621,483+6.8%
Total liabilities and equity795,146740,463687,538+7.4%
Goodwill10,1129,3089,422+8.6%
Intangible assets1,099335384+228.1%
Investments3,9043,8503,937+1.4%
Loans83,75480,28275,453+4.3%
Trading assets13,31913,10212,616+1.7%
Cash and equivalents19,79516,59815,821+19.3%
Other assets663,163616,988569,905+7.5%
Total assets795,146740,463687,538+7.4%

10-K for the year ended 31 December 2020, filed 19 February 2021: the filing.